Adipocytokines in subjects with and without ischemic cerebrovascular disease

Acta Neurologica Belgica

Volumn 110, Issue 3, 2010, Pages 234-238

  Jaleel, Anila ^a   Aqil, Saima ^b   Jaleel, Shahila ^c   Jaleel, Farhan ^d  

^a ZIAUDDIN UNIVERSITY   (Pakistan)

^b ALTAMASH INSTITUTE OF DENTAL MEDICINE   (Pakistan)

^c Department of Pathology   (Pakistan)

^d Fatima Jinnah Dental College   (Pakistan)

Author keywords

Adiponectin; Cerbrovascular disease; Interleukin 6; Ischemia; Leptin

Indexed keywords

ADIPONECTIN; GLUCOSE; INTERLEUKIN 6; LEPTIN; LIPID; ADIPONECTIN, HUMAN; IL6 PROTEIN, HUMAN;

ADULT; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; STROKE; AGED; BLOOD; CEREBROVASCULAR DISEASE; FEMALE; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED;

ADIPONECTIN; AGED; BRAIN ISCHEMIA; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEPTIN; MALE; MIDDLE AGED; STROKE;

EID: 79952110979     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Song JW, Song KS, Choi JR, Kim SY, Rhee JH. Plasma levels of IL-6 and its relationship to procoagulant and fibrinolytic markers in acute ischemic stroke. Yonsei Medical journal. 2006;47:201-6.
2. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama, H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa T, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y. Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients. Arteriosclerosis, Thrombosis, and Vascular Biolog. 2000;20:1595.
3. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-B signaling through a cAMP-dependent pathway. Circulation. 2000;102:1296-301.
4. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K. et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension. 2004;43:1318-22.
5. Sodenberg S, Colquhoun D, Keech A, Yallop J, Barnes EH, Pollicino C, Simes J, Tonkin AM, Nestel P. Leptin but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study. International Journal of Obesity. 2009;33:123-30.
6. Zhong F, Chen J. Leptin protects hippocampal CA1 neurons against ischemic injury. J Neurochem. 2008;107(2):578-87.
7. Van Snick J. Interleukin 6: an overview. Annu Rev immunol. 1990;8:253-78.
8. Dimmitris A, Papanicolaou, Ronald L, Wlilder, Stavros C, Manolagas, Chrousos. The pathophysiological roles of interleukin 6 in human disease. Annals of Internal Medicin. 1998;28(2):127-37.
9. Vicennati V, Vottero A, Friedman C, Papaicolaou DA. Hormonal regulation of interleukin 6 production in human adipocytes. Int J Obes Relat Metab Disord. 2002;26:905-11.
10. Acalovschi D, Wiest T, Hartmann M. et al. Multiple levels of regulation of the interleukin 6 system in stroke. Stroke. 2003;34(8):1864-9.
11. Dávalos A, Castillo J, Pumar JM, Noya M. Body temperature and fibrinogen are related to early neurological deterioration in acute ischemic stroke. Cerebrovasc Dis. 1997;7:64-9.
12. Nishimoto N, Sasai M, Shima Y. et al. Improvement in castlemans disease by humanized anti-interleukin 6 receptor antibody therapy. Blood. 2000;95:56-61.
13. Suominen P. Evaluation of an enzyme immunometric assay to measure serum adiponectin concentrations. Clin Chem. 2004;50(1):219-21.
14. Wallace AM. Measurement of leptin and leptin binding in the human circulation. Ann Clin Biochem. 2000;37:244-52.
15. Trinder P. Enzymatic determinations of blood glucose using glucose oxidase with an alternative oxygen acceoter. Am Clin Biochem. 1969;6:24.
16. Bucolo G, David H. Quantitative determination of serum triglycerides by use of enzymes. Clin Chem. 1973;19:476.
17. Allain CC, Poon LS, Chan CS. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470.
18. Bougousslavsky J, Barnett HJM, Fox AJ, Hachinski VC, Taylor W. Atherosclerotic disease of the cerebral artery. Stroke. 1986;17:1112-20 (Abstract).
19. Tera S, yilmaz G, Strokes KY, Ishikawa M, Kawase T, Granger DN. Inflammatory and injury responses to responses to ischemic stroke in obese mice. Stroke. 2008;39:943-50.
20. Norata GD, Raselli S, Grigore L. et al. Leptin: Adiponectin ratio is an independent predictor of intima media thickness of common carotid artery. Stroke. 2007;38:2844-6.
21. Ukkola O, Poykko S, Paivansalo M, Kesaniemi YA. Interaction between ghrelin, leptin and IGF-1 affect metabolic syndrome and early atherosclerosis. Ann Med. 2008;40:465-73.
22. Valerio A, Dossena M, Bertolotti P, Boroni F, Sarnico I, Faraco G, Chiarugi A, Frontini A, Giordano A, Liou HC, Grazia De Simoni M, Spano P, Carruba MO, Pizzi M, Nisoli E. Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-kappaB/c-Rel-dependent transcription. Stroke. 2009;40(2):610-7.
23. Schneiderman J, Simon AJ, Schroeter MR, Flugelman MY, Konstantinides S, Schaefer K. Leptin receptor is elevated in carotid plaques from neurologically symptomatic patients and positively correlated with augmented macrophage density. J Vasc Surg. 2008;48(5):1146-55.
24. Sodenberg S, Colquhoun D, Keech A, Yallop J, Barnes EH, Pollicino C, Simes J, Tonkin AM, and Nestel P. Leptin but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study. International Journal of Obesity. 2009;33:123-30.
25. Nishimura M, Izumiya Y, Higuchi A, Rei, Shibata, Qiu J, Kudo C, Shin HK, Michael A. Moskowitz, Ouchi N. Adiponectin Prevents Cerebral Ischemic Injury Through Endothelial Nitric Oxide Synthase-Dependent Mechanisms. Circulation. 2008;117:216-23.
26. Matsumoto M, Ishikawa S, Kajii E. Association of Adiponectin with Cerebrovascular Disease. A Nested Case-Control Study, Stroke. 2008;39:323.
27. Sasaki M, Kawano T., Saito T., Yuzawa M., Saito T, Ikoma A. et al. Hypoadiponectinemia in patients with cerebral infarction: comparison with other atherosclerotic disorders. Am J Med Sci. 2007;333(3):140-4.
28. Perini F, Morra M, Alecci M, Galloni E, Marchi M, Toso V. Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. Neurol Sci. 2001;22(4):287-8.
29. Welsh P, Lowe GD, Chalmers J, Campbell DJ, Rumley A, Neal BC, MacMahon SW, Woodward M. Associations of proinflammatory cytokines with the risk of recurrent stroke. Stroke. 2008;39(8):2226-30.